Market Closed -
TEL AVIV STOCK EXCHANGE
07:24:08 2024-04-25 am EDT
|
5-day change
|
1st Jan Change
|
1,747
ILa
|
-1.02%
|
|
-1.19%
|
-3.91%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,031
|
6,519
|
12,439
|
9,330
|
6,489
|
5,921
|
-
|
-
|
Enterprise Value (EV)
1 |
8,441
|
8,982
|
14,888
|
11,413
|
8,584
|
7,776
|
7,584
|
7,494
|
P/E ratio
|
12.7
x
|
509
x
|
16.1
x
|
4.34
x
|
10.1
x
|
13.3
x
|
10.1
x
|
9.7
x
|
Yield
|
4.67%
|
1.97%
|
3.21%
|
12.6%
|
5.36%
|
4.05%
|
4.94%
|
5.16%
|
Capitalization / Revenue
|
1.14
x
|
1.29
x
|
1.79
x
|
0.93
x
|
0.86
x
|
0.84
x
|
0.8
x
|
0.8
x
|
EV / Revenue
|
1.6
x
|
1.78
x
|
2.14
x
|
1.14
x
|
1.14
x
|
1.1
x
|
1.02
x
|
1.01
x
|
EV / EBITDA
|
7.05
x
|
9.07
x
|
9.07
x
|
2.85
x
|
4.89
x
|
5.58
x
|
4.69
x
|
4.35
x
|
EV / FCF
|
18.1
x
|
40.6
x
|
32.8
x
|
8.68
x
|
10.5
x
|
26.5
x
|
16.1
x
|
14.4
x
|
FCF Yield
|
5.53%
|
2.46%
|
3.05%
|
11.5%
|
9.49%
|
3.77%
|
6.21%
|
6.97%
|
Price to Book
|
1.54
x
|
1.66
x
|
2.75
x
|
1.71
x
|
1.13
x
|
0.99
x
|
0.94
x
|
0.9
x
|
Nbr of stocks (in thousands)
|
1,280,351
|
1,280,551
|
1,287,151
|
1,287,151
|
1,289,256
|
1,289,565
|
-
|
-
|
Reference price
2 |
4.710
|
5.091
|
9.664
|
7.248
|
5.033
|
4.591
|
4.591
|
4.591
|
Announcement Date
|
2/13/20
|
2/11/21
|
2/9/22
|
2/15/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
5,271
|
5,043
|
6,955
|
10,015
|
7,536
|
7,038
|
7,420
|
7,398
|
EBITDA
1 |
1,198
|
990
|
1,642
|
4,007
|
1,754
|
1,394
|
1,616
|
1,722
|
EBIT
1 |
760
|
509
|
1,194
|
3,509
|
1,218
|
856.8
|
1,058
|
1,178
|
Operating Margin
|
14.42%
|
10.09%
|
17.17%
|
35.04%
|
16.16%
|
12.17%
|
14.25%
|
15.92%
|
Earnings before Tax (EBT)
1 |
628
|
49
|
1,092
|
3,404
|
974
|
688.4
|
860.5
|
908.8
|
Net income
1 |
475
|
11
|
783
|
2,159
|
647
|
446.1
|
586.5
|
611
|
Net margin
|
9.01%
|
0.22%
|
11.26%
|
21.56%
|
8.59%
|
6.34%
|
7.9%
|
8.26%
|
EPS
2 |
0.3700
|
0.0100
|
0.6000
|
1.670
|
0.5000
|
0.3445
|
0.4538
|
0.4734
|
Free Cash Flow
1 |
467
|
221
|
454
|
1,315
|
815
|
293.5
|
471
|
522
|
FCF margin
|
8.86%
|
4.38%
|
6.53%
|
13.13%
|
10.81%
|
4.17%
|
6.35%
|
7.06%
|
FCF Conversion (EBITDA)
|
38.98%
|
22.32%
|
27.65%
|
32.82%
|
46.47%
|
21.06%
|
29.14%
|
30.31%
|
FCF Conversion (Net income)
|
98.32%
|
2,009.09%
|
57.98%
|
60.91%
|
125.97%
|
65.79%
|
80.3%
|
85.43%
|
Dividend per Share
2 |
0.2200
|
0.1005
|
0.3100
|
0.9100
|
0.2700
|
0.1860
|
0.2270
|
0.2367
|
Announcement Date
|
2/13/20
|
2/11/21
|
2/9/22
|
2/15/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
1,790
|
2,038
|
2,525
|
2,880
|
2,519
|
2,091
|
-
|
-
|
-
|
1,690
|
1,773
|
1,726
|
1,939
|
1,779
|
-
|
EBITDA
1 |
421
|
575
|
1,002
|
1,258
|
1,049
|
698
|
610
|
-
|
346
|
357
|
347.3
|
346
|
355.6
|
368.9
|
-
|
EBIT
1 |
315
|
458
|
-
|
1,139
|
928
|
562
|
-
|
-
|
-
|
211
|
207.5
|
212.1
|
213.6
|
202.7
|
-
|
Operating Margin
|
17.6%
|
22.47%
|
-
|
39.55%
|
36.84%
|
26.88%
|
-
|
-
|
-
|
12.49%
|
11.71%
|
12.29%
|
11.02%
|
11.4%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
117
|
190.6
|
224.1
|
241.1
|
-
|
-
|
Net income
1 |
225
|
283
|
-
|
563
|
633
|
331
|
280
|
163
|
137
|
67
|
98.27
|
101
|
120.6
|
124.8
|
-
|
Net margin
|
12.57%
|
13.89%
|
-
|
19.55%
|
25.13%
|
15.83%
|
-
|
-
|
-
|
3.96%
|
5.54%
|
5.85%
|
6.22%
|
7.01%
|
-
|
EPS
2 |
0.1700
|
0.2100
|
-
|
0.4400
|
0.4900
|
0.2500
|
0.2200
|
0.1300
|
0.1100
|
0.0500
|
0.0761
|
0.0782
|
0.0934
|
0.0967
|
-
|
Dividend per Share
2 |
0.0800
|
0.1300
|
0.2400
|
0.2918
|
0.2435
|
0.1400
|
-
|
-
|
-
|
0.0500
|
0.0408
|
0.0478
|
0.0576
|
0.0572
|
-
|
Announcement Date
|
11/4/21
|
2/9/22
|
5/11/22
|
7/27/22
|
11/9/22
|
2/15/23
|
5/10/23
|
8/9/23
|
11/8/23
|
2/28/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
2,410
|
2,463
|
2,449
|
2,083
|
2,095
|
1,855
|
1,663
|
1,573
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.012
x
|
2.488
x
|
1.491
x
|
0.5198
x
|
1.194
x
|
1.331
x
|
1.029
x
|
0.9133
x
|
Free Cash Flow
1 |
467
|
221
|
454
|
1,315
|
815
|
294
|
471
|
522
|
ROE (net income / shareholders' equity)
|
12.4%
|
6.57%
|
18.5%
|
43.2%
|
11.5%
|
7.41%
|
10.6%
|
10.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
3.070
|
3.070
|
3.520
|
4.240
|
4.470
|
4.650
|
4.880
|
5.110
|
Cash Flow per Share
2 |
0.7700
|
0.6300
|
0.8300
|
1.570
|
1.240
|
0.9100
|
0.8600
|
-
|
Capex
1 |
576
|
626
|
611
|
747
|
780
|
815
|
750
|
750
|
Capex / Sales
|
10.93%
|
12.41%
|
8.79%
|
7.46%
|
10.35%
|
11.58%
|
10.11%
|
10.14%
|
Announcement Date
|
2/13/20
|
2/11/21
|
2/9/22
|
2/15/23
|
2/28/24
|
-
|
-
|
-
|
Last Close Price
4.591
USD Average target price
5.48
USD Spread / Average Target +19.35% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.91% | 5.91B | | -.--% | 11.15B | | -7.28% | 7.3B | | +7.47% | 6.87B | | -6.14% | 5.54B | | -10.44% | 5.6B | | +31.35% | 5.19B | | -13.45% | 4.58B | | +17.77% | 4.4B | | +6.27% | 3.84B |
Other Agricultural Chemicals
|